Adverse effects of antidepressant use in pregnancy: An evaluation of fetal growth and preterm birth

Depression and Anxiety

Volumn 27, Issue 1, 2010, Pages 35-38

  Einarson, A ^a   Choi, J ^a   Einarson, T R ^b   Koren, G ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Depression; Outcomes; Pregnancy

Indexed keywords

ALCOHOL; AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; MIRTAZAPINE; NEFAZODONE; PAROXETINE; SERTRALINE; TRAZODONE; VENLAFAXINE;

ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; DATA BASE; DEPRESSION; DRUG USE; FEMALE; FETUS GROWTH; GESTATIONAL AGE; HEALTH PROGRAM; HUMAN; INCIDENCE; INFANT; LIVE BIRTH; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; SMALL FOR DATE INFANT; SMOKING; STATISTICAL SIGNIFICANCE;

ADULT; ANTIDEPRESSIVE AGENTS; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; FETAL GROWTH RETARDATION; HUMANS; INCIDENCE; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; OBSTETRIC LABOR, PREMATURE; ONTARIO; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RISK; STATISTICS AS TOPIC;

EID: 75749143042     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.20598     Document Type: Article

References (23)

1. Morrison JJ, Rennie JM. Clinical, scientific and ethical aspects of fetal and neonatal care at extremely preterm periods of gestation. Br J Obstet Gynaecol 1997;104:1341-1350.
2. Li D, Liu L, Odouli R. Presence of depressive symptoms during early pregnancy and the risk of preterm delivery: a prospective cohort study. Hum Reprod 2009;24:146-153.
3. Suri R, Altshuler L, Hellemann G, Burt VK, Aquino A, Mintz J. Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth. Am J Psychiatry 2007;164:1206-1213.
4. Lennestål R, Källén B. Delivery outcome in relation to maternal use of some recently introduced antidepressants. J Clin Psychopharmacol 2007;27:607-613.
5. Djulus J, Koren G, Einarson TR, et al. Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes. J Clin Psychiatry 2006;67:1280-1284.
6. Maschi S, Clavenna A, Campi R, Schiavetti B, Bernat M, Bonati M. Neonatal outcome following pregnancy exposure to antidepressants: a prospective controlled cohort study. BJOG 2008;115:283-289.
7. Malm H, Klaukka T, Neuvonen PJ. Risks associated with selective serotonin reuptake inhibitors in pregnancy. Obstet Gynecol 2005;106:1289-1296.
8. Sivojelezova A, Shuhaiber S, Sarkissian L, Einarson A, Koren G. Citalopram use in pregnancy: prospective comparative evaluation of pregnancy and fetal outcome. Am J Obstet Gynecol 2005;193:2004-2009.
9. Pearson KH, Nonacs RM, Viguera AC, et al. Birth outcomes following prenatal exposure to antidepressants. J Clin Psychiatry 2007;68:1277-1278.
10. Diav-Citrin O, Shechtman S,Weinbaum D, et al. Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study. Br J Clin Pharmacol 2008;66:695-705.
11. Campos D, Santos DC, Gonc-alves VM, Goto MM, Campos-Zanelli TM. Motor performance of infants born small or appropriate for gestational age: a comparative study. Pediatr Phys Ther 2008;20:340-346.
12. Gutbrod T, Wolke D, Soehne B, Ohrt B, Riegel K. Effects of gestation and birth weight on the growth and development of very low birthweight small for gestational age infants: a matched group comparison. Arch Dis Child Fetal Neonatal Ed 2000;82:F208-F214.
13. Barros FC, Vëlez Mdel P. Temporal trends of preterm birth subtypes and neonatal outcomes. Obstet Gynecol 2006;107:1035-1041.
14. Källën B. Neonate characteristics after maternal use of antidepressants in late pregnancy. Arch Pediatr Adolesc Med 2004;158:312-316.
15. Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 1996;335:1010-1015.
16. Simon GE, Cunningham M, Davis RL. Outcomes of prenatal antidepressant exposure. Am J Psychiatry 2002;159:2055-2061.
17. Chun-Fai-Chan B, Koren G, Fayez I, et al. Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. Am J Obstet Gynecol 2005;192:932-936.
18. Suri R, Altshuler L, Hendrick V, Rasgon N, Lee E, Mintz J. The impact of depression and fluoxetine treatment on obstetrical outcome. Arch Womens Ment Health 2004;7:193-200.
19. Wisner KL, Sit DK, Hanusa BH, et al. Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes. Am J Psychiatry 2009;166:557-566.
20. Maina G, Saracco P, Giolito MR, Danelon D, Bogetto F, Todros T. Impact of maternal psychological distress on fetal weight, prematurity and intrauterine growth retardation. J Affect Disord 2008;111:214-220.
21. Glynn LM, Schetter CD, Hobel CJ, Sandman CA. Pattern of perceived stress and anxiety in pregnancy predicts preterm birth. Health Psychol 2008;27:43-51.
22. Diego MA, Jones NA, Field T, et al. Maternal psychological distress, prenatal cortisol, and fetal weight. Psychosom Med 2006;68:747-753.
23. Neggers Y, Goldenberg R, Cliver S, Hauth J. The relationship between psychosocial profile, health practices, and pregnancy outcomes. Acta Obstet Gynecol Scand 2006;85:277-285.